Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Pract Neurol ; 24(4): 320-325, 2024 Jul 16.
Artigo em Inglês | MEDLINE | ID: mdl-38290842

RESUMO

A 41-year-old man developed rapidly progressive cranial neuropathies and muscle weakness followed by respiratory failure, requiring ventilation support. On examination, there was marked bilateral ptosis and ophthalmoplegia with bulbar, neck and proximal upper limb weakness. He had a recent open left humeral fracture that eventually required amputation. Despite immunoglobulin therapy, his progressive weakness continued. Multiple investigation results were inconclusive. Eventually, botulinum type A toxin was found positive, by which time the therapeutic window for antitoxin had passed. He continued on supportive management and was treated for concomitant infections and nosocomial illnesses. He was subsequently weaned from respiratory support and has made a good neurological recovery.


Assuntos
Botulismo , Humanos , Masculino , Adulto , Botulismo/complicações , Botulismo/diagnóstico , Botulismo/terapia , Toxinas Botulínicas Tipo A/uso terapêutico
2.
Clin Med (Lond) ; 13(2): 152-9, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23681863

RESUMO

As the recent outbreaks in Edinburgh and Camarthen, UK, have shown, Legionella pneumonia (LP) remains a significant public health problem, which is not only confined to those who have travelled abroad. In both outbreaks and sporadic cases, diagnosis can go unrecognised. We reviewed the demographics, comorbidities, diagnosis, treatment and clinical outcome of LP cases over five years in a district general hospital in northwest England. Over half of LP cases were UK acquired and 'classic' clinical features were common. Clinical criteria for diagnosing LP were confirmed, but few sputum samples were sent to reference laboratories, limiting further essential epidemiological mapping of UK cases. Following current UK community-acquired pneumonia guidance would have missed nearly one quarter of LP cases in our series, potentially leading to further morbidity and mortality.


Assuntos
Legionella pneumophila , Doença dos Legionários/diagnóstico , Doença dos Legionários/tratamento farmacológico , Fatores Etários , Idoso , Antibacterianos/uso terapêutico , Antígenos de Bactérias/urina , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/urina , Comorbidade , Inglaterra , Feminino , Hospitais Públicos , Humanos , Legionella pneumophila/imunologia , Doença dos Legionários/urina , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA